MX391087B - Método para purificar eritropoyetina pegilada. - Google Patents

Método para purificar eritropoyetina pegilada.

Info

Publication number
MX391087B
MX391087B MX2018016033A MX2018016033A MX391087B MX 391087 B MX391087 B MX 391087B MX 2018016033 A MX2018016033 A MX 2018016033A MX 2018016033 A MX2018016033 A MX 2018016033A MX 391087 B MX391087 B MX 391087B
Authority
MX
Mexico
Prior art keywords
erythropoietin
employing
residue
ethylene glycol
cation exchange
Prior art date
Application number
MX2018016033A
Other languages
English (en)
Other versions
MX2018016033A (es
Inventor
Bernhard Spensberger
Roberto Falkenstein
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MX2018016033A publication Critical patent/MX2018016033A/es
Publication of MX391087B publication Critical patent/MX391087B/es

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
    • B01D15/361—Ion-exchange
    • B01D15/362—Cation-exchange
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/505—Erythropoietin [EPO]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a un método para la purificación de una proteína que comprende eritropoyetina y un residuo único de poli(etilenglicol) a partir de productos secundarios de reacción o material inicial que no ha reaccionado, por un método de cromatografía de intercambio catiónico. Se ha encontrado que al usar un material de cromatografía de intercambio catiónico ToyopearlMR SP-650 y usando una segunda etapa de lavado con un valor de pH incrementado en comparación con la primera etapa de lavado se puede obtener una proteína de fusión de eritropoyetina y un residuo único de poli(etilenglicol) en una etapa única con alta pureza y rendimiento, y adecuado para aplicaciones a gran escala.
MX2018016033A 2016-07-15 2017-07-13 Método para purificar eritropoyetina pegilada. MX391087B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16179755 2016-07-15
PCT/EP2017/067790 WO2018011381A1 (en) 2016-07-15 2017-07-13 Method for purifying pegylated erythropoietin

Publications (2)

Publication Number Publication Date
MX2018016033A MX2018016033A (es) 2019-05-13
MX391087B true MX391087B (es) 2025-03-21

Family

ID=56497564

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018016033A MX391087B (es) 2016-07-15 2017-07-13 Método para purificar eritropoyetina pegilada.

Country Status (14)

Country Link
US (3) US20190300567A1 (es)
EP (1) EP3484911B1 (es)
JP (2) JP7177035B2 (es)
KR (2) KR102820834B1 (es)
CN (1) CN109415427A (es)
AU (1) AU2017295037B2 (es)
ES (1) ES2841648T3 (es)
HR (1) HRP20202077T1 (es)
IL (1) IL264153B (es)
MX (1) MX391087B (es)
PL (1) PL3484911T3 (es)
SG (1) SG11201811553UA (es)
SI (1) SI3484911T1 (es)
WO (1) WO2018011381A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018011381A1 (en) 2016-07-15 2018-01-18 F. Hoffmann-La Roche Ag Method for purifying pegylated erythropoietin

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5118796A (en) 1987-12-09 1992-06-02 Centocor, Incorporated Efficient large-scale purification of immunoglobulins and derivatives
FR2646438B1 (fr) 1989-03-20 2007-11-02 Pasteur Institut Procede de remplacement specifique d'une copie d'un gene present dans le genome receveur par l'integration d'un gene different de celui ou se fait l'integration
SG88714A1 (en) 1989-11-06 2002-05-21 Cell Genesys Inc Production of proteins using homologous recombination
DE779362T1 (de) 1989-12-22 2001-04-05 Applied Research Systems Ars Holding N.V., Curacao DNS-Konstrukten zur Aktivierung und Veränderung der Expression von endogenen Genen
JPH04218000A (ja) 1990-02-13 1992-08-07 Kirin Amgen Inc 修飾ポリペプチド
JP3051145B2 (ja) 1990-08-28 2000-06-12 住友製薬株式会社 新規なポリエチレングリコール誘導体修飾ペプチド
DE4118912C1 (es) 1991-06-08 1992-07-02 Biotest Pharma Gmbh, 6072 Dreieich, De
US5641670A (en) 1991-11-05 1997-06-24 Transkaryotic Therapies, Inc. Protein production and protein delivery
NZ245015A (en) 1991-11-05 1995-12-21 Transkaryotic Therapies Inc Delivery of human growth hormone through the administration of transfected cell lines encoding human growth hormone, which are physically protected from host immune response; the transfected cells and their production
US5968502A (en) 1991-11-05 1999-10-19 Transkaryotic Therapies, Inc. Protein production and protein delivery
FR2686899B1 (fr) 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
DE69332377T2 (de) 1992-07-13 2003-07-03 Bionebraska, Inc. Verfahren zur modifizierung rekombinanter polypeptide
TW402639B (en) 1992-12-03 2000-08-21 Transkaryotic Therapies Inc Protein production and protein delivery
JPH08176133A (ja) * 1994-12-26 1996-07-09 Takeda Chem Ind Ltd L−アスコルビン酸の精製法
US5932462A (en) 1995-01-10 1999-08-03 Shearwater Polymers, Inc. Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
ATE370961T1 (de) 1998-05-06 2007-09-15 Genentech Inc Reinigung von antikörpern durch ionenaustauschchromatographie
WO2000044785A1 (en) 1999-01-29 2000-08-03 F. Hoffmann-La Roche Ag Gcsf conjugates
CZ299516B6 (cs) 1999-07-02 2008-08-20 F. Hoffmann-La Roche Ag Konjugát erythropoetinového glykoproteinu, zpusobjeho výroby a použití a farmaceutická kompozice sjeho obsahem
PE20010288A1 (es) * 1999-07-02 2001-03-07 Hoffmann La Roche Derivados de eritropoyetina
JP5179689B2 (ja) 2000-02-11 2013-04-10 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング 抗体ベース融合タンパク質の循環系内半減期の増強
US20050100991A1 (en) 2001-04-12 2005-05-12 Human Genome Sciences, Inc. Albumin fusion proteins
PT1543038T (pt) 2002-09-11 2017-07-07 Genentech Inc Purificação de proteína
US7610156B2 (en) 2003-03-31 2009-10-27 Xencor, Inc. Methods for rational pegylation of proteins
WO2005021710A2 (en) 2003-06-02 2005-03-10 University Of Miami Chimeric molecules and methods of use
AR067537A1 (es) * 2007-07-17 2009-10-14 Hoffmann La Roche Purificacion de polipeptidos pegilados
HUE024877T2 (en) 2007-10-30 2016-02-29 Genentech Inc Antibody purification by cation exchange chromatography
DE102008002209A1 (de) 2008-06-04 2009-12-10 Evonik Degussa Gmbh Verfahren zur Aufreinigung von Erythropoietin
CA2736141C (en) 2008-09-23 2018-03-20 F. Hoffmann-La Roche Ag Purification of erythropoietin
JP5788803B2 (ja) 2008-12-02 2015-10-07 ノヴォ・ノルディスク・ヘルス・ケア・アーゲー ポリペプチド精製
BR112012016882B1 (pt) * 2010-01-08 2021-02-23 University Of Tasmania método de armazenamento de um fluido corpóreo para análise futura
ES2500048T3 (es) 2010-09-14 2014-09-29 F. Hoffmann-La Roche Ag Procedimiento para purificar eritropoyetina pegilada
WO2018011381A1 (en) * 2016-07-15 2018-01-18 F. Hoffmann-La Roche Ag Method for purifying pegylated erythropoietin

Also Published As

Publication number Publication date
IL264153B (en) 2021-09-30
EP3484911A1 (en) 2019-05-22
KR20190026759A (ko) 2019-03-13
US20250136639A1 (en) 2025-05-01
KR102470282B1 (ko) 2022-11-24
HRP20202077T1 (hr) 2021-02-19
US20210155655A1 (en) 2021-05-27
KR20220158870A (ko) 2022-12-01
JP7177035B2 (ja) 2022-11-22
SG11201811553UA (en) 2019-01-30
AU2017295037A1 (en) 2019-01-24
JP7530413B2 (ja) 2024-08-07
CN109415427A (zh) 2019-03-01
WO2018011381A1 (en) 2018-01-18
JP2019524726A (ja) 2019-09-05
US20190300567A1 (en) 2019-10-03
US11993630B2 (en) 2024-05-28
BR112018076390A2 (pt) 2019-03-26
EP3484911B1 (en) 2020-11-04
ES2841648T3 (es) 2021-07-08
AU2017295037B2 (en) 2021-07-22
PL3484911T3 (pl) 2021-03-08
MX2018016033A (es) 2019-05-13
IL264153A (en) 2019-02-28
SI3484911T1 (sl) 2021-02-26
CA3027143A1 (en) 2018-01-18
KR102820834B1 (ko) 2025-06-13
JP2023015257A (ja) 2023-01-31

Similar Documents

Publication Publication Date Title
IT201900025039A1 (it) Processo per purificare il bis(2-idrossietil)tereftalato.
SA517382081B1 (ar) عملية تقطير لإنتاج حمض أكريليك
EA201590629A1 (ru) Новые лиганды rig-i и способы их получения
WO2014149387A8 (en) Solid phase peptide synthesis processes and associated systems
WO2014178078A3 (en) Novel cloning, expression & purification method for the preparation of ranibizumab
WO2015024739A3 (en) Detergent composition comprising protease variants
EA201490568A1 (ru) Варианты глюкоамилазы и кодирующие их полинуклеотиды
BRPI0712272A2 (pt) Processos para a fabricação de pelo menos um isoocteno, de produtos de reação, de pelo menos um isooctano e de pelos menos um isooctanol
MX2013002554A (es) Metodo para purificar eritropoyetina conjugada con polietilenglicol (peg).
CL2020000087A1 (es) Cromatografía.
EA201992709A1 (ru) Способ получения оптически активного соединения
MX382218B (es) Variantes de lipasa y polinucleotidos que las codifican.
BR112015021785A2 (pt) Promotores de levedura para expressão de proteína
WO2013189972A3 (en) Use of polypeptides having protease activity in animal feed and detergents
EA201892211A3 (ru) Способ получения азоксистробина
WO2014122161A3 (en) Use of polypeptides having protease activity in animal feed
AR117002A2 (es) Proceso para la preparación de inhibidores de quinasa c-fms
BR112022006052A2 (pt) Processo para a preparação de protioconazol
PT3784649T (pt) Processo de síntese do ácido (s)-3-amino-4-(difluorometilenil)ciclopent-1-eno-1-carboxílico
BR112019009078A2 (pt) processo para a purificação de pirazolpiridazinas, sal e composição agrícola
MX2014001861A (es) Polipeptidos con actividad proteasa.
EA201890795A1 (ru) Способ прямого получения диметилового эфира гликоля и совместного получения этиленгликоля из монометилового эфира этиленгликоля
MX374783B (es) Procedimiento para purificar darbepoyetina alfa.
BR112016006865A2 (pt) berberinas substituídas e suas sínteses
EA201301294A1 (ru) Получение высокочистых мультисубъединичных белков, таких как антитела, в трансформированных микроорганизмах, например pichia pastoris